138 related articles for article (PubMed ID: 17404728)
1. Metallopeptidase, neurolysin, as a novel molecular tool for analysis of properties of cancer-producing matrix metalloproteinases-2 and -9.
Kadonosono T; Kato M; Ueda M
Appl Microbiol Biotechnol; 2007 Jul; 75(6):1285-91. PubMed ID: 17404728
[TBL] [Abstract][Full Text] [Related]
2. Alteration of substrate specificity of rat neurolysin from matrix metalloproteinase-2/9-type to -3-type specificity by comprehensive mutation.
Kadonosono T; Kato-Murai M; Ueda M
Protein Eng Des Sel; 2008 Aug; 21(8):507-13. PubMed ID: 18499680
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of rat brain neurolysin disclosed by molecular display system and putative substrates in rat tissues.
Kadonosono T; Kato M; Ueda M
Appl Microbiol Biotechnol; 2007 Jul; 75(6):1353-60. PubMed ID: 17401561
[TBL] [Abstract][Full Text] [Related]
4. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
[TBL] [Abstract][Full Text] [Related]
5. Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides.
Xu X; Wang Y; Lauer-Fields JL; Fields GB; Steffensen B
Matrix Biol; 2004 Jun; 23(3):171-81. PubMed ID: 15296945
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of matrix metalloproteinases in urine of cancer patients.
Moses MA; Wiederschain D; Loughlin KR; Zurakowski D; Lamb CC; Freeman MR
Cancer Res; 1998 Apr; 58(7):1395-9. PubMed ID: 9537238
[TBL] [Abstract][Full Text] [Related]
8. Characterization of plasma gelsolin as a substrate for matrix metalloproteinases.
Park SM; Hwang IK; Kim SY; Lee SJ; Park KS; Lee ST
Proteomics; 2006 Feb; 6(4):1192-9. PubMed ID: 16421935
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein C-II is a novel substrate for matrix metalloproteinases.
Kim SY; Park SM; Lee ST
Biochem Biophys Res Commun; 2006 Jan; 339(1):47-54. PubMed ID: 16314153
[TBL] [Abstract][Full Text] [Related]
10. [Metalloproteinases in the extracellular matrix: structure and activity].
Cuvelier A; Kuntz C; Sesboüé R; Muir JF; Martin JP
Rev Mal Respir; 1997 Jan; 14(1):1-10. PubMed ID: 9082500
[TBL] [Abstract][Full Text] [Related]
11. The other side of MMPs: protective roles in tumor progression.
Martin MD; Matrisian LM
Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
Benekareddy M; Mehrotra P; Kulkarni VA; Ramakrishnan P; Dias BG; Vaidya VA
Synapse; 2008 Aug; 62(8):590-600. PubMed ID: 18509851
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis.
Xue M; March L; Sambrook PN; Jackson CJ
Arthritis Rheum; 2007 Sep; 56(9):2864-74. PubMed ID: 17763449
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
Matsumoto Y; Park IK; Kohyama K
J Immunol; 2009 Oct; 183(7):4773-81. PubMed ID: 19734212
[TBL] [Abstract][Full Text] [Related]
16. Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.
Szécsi J; Drury R; Josserand V; Grange MP; Boson B; Hartl I; Schneider R; Buchholz CJ; Coll JL; Russell SJ; Cosset FL; Verhoeyen E
Mol Ther; 2006 Nov; 14(5):735-44. PubMed ID: 16784893
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis.
Denney H; Clench MR; Woodroofe MN
Biochem Biophys Res Commun; 2009 May; 382(2):341-7. PubMed ID: 19281798
[TBL] [Abstract][Full Text] [Related]
18. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
Sliwowska I; Kopczyński Z
Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
[TBL] [Abstract][Full Text] [Related]
19. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
20. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
